Valuation SMAIO

Stocks

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-24 EDT			5-day change	1st Jan Change
8.300 ^EUR	+1.22%		+9.79%	+32.80%

07-16	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-16	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16.99	16.1	13.46	35.24	46.75	-	-
Change	-	-5.23%	-16.43%	161.89%	32.64%	-	-
Enterprise Value (EV) ¹	11.95	12.4	12.54	34.26	45.25	45.85	46.55
Change	-	3.81%	1.07%	173.25%	32.09%	1.33%	1.53%
P/E	-	15.2x	-5.73x	-15.2x	-21.3x	208x	38.6x
PBR	-	-	-	-	7.55x	7.55x	6.38x
PEG	-	-	0x	1.71x	4.37x	-2x	0x
Capitalization / Revenue	7.08x	2.99x	2.45x	3.83x	4.25x	2.92x	2.24x
EV / Revenue	4.98x	2.3x	2.28x	3.72x	4.11x	2.87x	2.23x
EV / EBITDA	-4.7x	6.02x	-7.16x	-28.1x	-41.1x	31.6x	18.3x
EV / EBIT	-2.99x	16.8x	-3.94x	-13x	-17.4x	-306x	58.2x
EV / FCF	2.34x	-9.16x	-4.19x	-26.5x	-16.5x	-36.7x	-466x
FCF Yield	42.7%	-10.9%	-23.8%	-3.78%	-6.08%	-2.73%	-0.21%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-	0.2024	-0.45	-0.41	-0.39	0.04	0.215
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	2.4	5.383	5.498	9.2	11	16	20.9
EBITDA ¹	-2.544	2.059	-1.751	-1.22	-1.1	1.45	2.55
EBIT ¹	-4	0.7368	-3.184	-2.628	-2.6	-0.15	0.8
Net income ¹	2.846	1.058	-2.349	-2.229	-2.25	0.25	1.2
Net Debt ¹	-5.044	-3.7	-0.921	-0.9873	-1.5	-0.9	-0.2
Reference price ²	3.250	3.080	2.580	6.250	8.300	8.300	8.300
Nbr of stocks (in thousands)	5,229	5,229	5,216	5,639	5,633	-	-
Announcement Date	4/11/23	4/29/24	4/24/25	4/27/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SMAIO	-21.28x	4.11x	-41.14x	-	53.23M
ELI LILLY AND COMPANY	35.93x	12.68x	26.75x	0.57%	1,067B
JOHNSON & JOHNSON	28.24x	6.45x	17.87x	2.04%	635B
ABBVIE INC.	33.87x	7.65x	15.73x	2.65%	458B
ROCHE HOLDING AG	19.22x	4.69x	11.59x	2.82%	347B
NOVARTIS AG	21.56x	5.71x	14.24x	2.81%	295B
ASTRAZENECA PLC	21.1x	4.45x	12.31x	1.98%	262B
NOVO NORDISK A/S	14.14x	5.26x	10.84x	3.54%	216B
AMGEN INC.	24.66x	6.48x	11.43x	2.68%	203B
GILEAD SCIENCES, INC.	-46.58x	5.59x	30.88x	2.55%	161B
Average	13.08x	6.31x	11.05x	2.4%	364.36B
Weighted average by Cap.	24.95x	7.95x	18.70x	1.96%